CRMDCorMedix Inc.

$518M

Q3 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$59,530-84.0% YoY

Gross Profit

-$19,496-32.7% margin

Operating Income

-$5M-8687.2% margin

Net Income

-$5M-8844.0% margin

EPS (Diluted)

$-0.22

QoQ Revenue Growth

+68.8%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$570,612

Balance Sheet

Total Assets

$34M

Total Liabilities

$5M

Stockholders' Equity

$29M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$59,530	$372,514	-84.0%
Gross Profit	-$19,496	$60,080	-132.5%
Operating Income	-$5M	-$10M	+49.5%
Net Income	-$5M	-$10M	+48.6%

CRMD Q3 2019 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena